Holen Sie sich die Stockscreener-App
5.70
0.70%
-0.04
Handel nachbörslich:
5.74
0.04
+0.70%
Schlusskurs vom Vortag:
$5.74
Offen:
$5.67
24-Stunden-Volumen:
78,710
Relative Volume:
0.12
Marktkapitalisierung:
$11.94M
Einnahmen:
$7.11M
Nettoeinkommen (Verlust:
$-41.28M
KGV:
-4.1304
EPS:
-1.38
Netto-Cashflow:
$-26.84M
1W Leistung:
+5.15%
1M Leistung:
-49.27%
6M Leistung:
-31.41%
1J Leistung:
-81.00%
1-Tages-Spanne:
$5.50
$6.17
1-Wochen-Bereich:
$4.84
$6.17
52-Wochen-Spanne:
$4.84
$46.50
Co Diagnostics Inc Stock (CODX) Company Profile
Firmenname
Co Diagnostics Inc
Sektor
Branche
Telefon
(801) 278-9769
Adresse
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Vergleichen Sie CODX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
5.70 | 12.03M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-08-12 | Herabstufung | Sidoti | Buy → Neutral |
| 2021-12-29 | Eingeleitet | Sidoti | Buy |
| 2021-03-29 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-05-20 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-05-18 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-09 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-03 | Herabstufung | Maxim Group | Buy → Hold |
Alle ansehen
Co Diagnostics Inc Aktie (CODX) Neueste Nachrichten
CODX stock plunges to all-time lows on 1-for-30 reverse stock split approval - MSN
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention and Expo on Oct 2-3 - marketscreener.com
CODX Shares Dip Despite Australian Patent Grant for Co-Dx PCR Platform - Finviz
Co-Diagnostics Approves Reverse Stock Split to Maintain Listing - The Globe and Mail
Co-Diagnostics announces 1-for-30 reverse stock split - Yahoo Finance
Institution Moves: Is Co Diagnostics Inc stock a buy in volatile marketsDip Buying & Daily Volume Surge Trade Alerts - moha.gov.vn
Co-Diagnostics (CODX) Announces 1-for-30 Reverse Stock Split - GuruFocus
Co-Diagnostics to Effect a 1-for-30 Reverse Stock Split - marketscreener.com
CODX Stock Plunges To All-Time Lows On 1-for-30 Reverse Stock Split Approval - Stocktwits
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split By Investing.com - Investing.com South Africa
Co-Diagnostics announces 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Co-Diagnostics stock plunges after announcing 1-for-30 reverse split - Investing.com India
Biotech Co-Diagnostics shrinks share count 30-to-1 to stay on Nasdaq - Stock Titan
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies - The Malaysian Reserve
Co-Diagnostics Receives Grant of Australian Patent Covering Co-D - GuruFocus
Co-Diagnostics (CODX) Secures Australian Patent for PCR Platform - GuruFocus
Co-diagnostics receives Australian patent for PCR testing platform - Investing.com India
Co-diagnostics receives Australian patent for PCR testing platform By Investing.com - Investing.com Nigeria
New point-of-care PCR tech for flu and COVID secures patent in Australia - Stock Titan
Co-Diagnostics Q3 2025 Earnings Preview - MSN
Aug Breakouts: How resilient is Co Diagnostics Inc. stock in market downturns - Улправда
Can Co Diagnostics Inc. stock sustain market leadershipWeekly Trade Report & Low Drawdown Momentum Trade Ideas - Улправда
Why Co Diagnostics Inc. stock is seen as undervaluedJuly 2025 Update & Stepwise Trade Signal Guides - Улправда
Will Co Diagnostics Inc. stock deliver consistent dividends2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - DonanımHaber
Can Co Diagnostics Inc. stock weather global recession2025 Trading Volume Trends & Reliable Price Breakout Signals - ulpravda.ru
Bond Watch: Is Co Diagnostics Inc. stock a buy in volatile markets2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - DonanımHaber
How resilient is Co Diagnostics Inc. stock in market downturnsPortfolio Risk Summary & AI Forecast Swing Trade Picks - Улправда
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in - GuruFocus
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India - Barchart.com
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Con - GuruFocus
Co-Diagnostics (CODX) Validates Efficacy of Influenza and COVID-19 Detection Test - GuruFocus
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation - Nasdaq
Co Diagnostics Inc Stock Analysis and ForecastRisk Mitigation Techniques & Affordable Trading Techniques - earlytimes.in
Certain Warrants of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Certain Stock Options of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
48,142,582 Common Stock of Co-Diagnostics, Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Value Recap: Will Co Diagnostics Inc stock deliver consistent dividendsMarket Growth Summary & High Accuracy Swing Entry Alerts - moha.gov.vn
Co-Diagnostics, Arabian Eagle to Develop and Commercialize Co-Dx Tech - Medical Product Outsourcing
Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN
CapEx per share of Co-Diagnostics, Inc. – MUN:C97 - TradingView — Track All Markets
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025 - Barchart.com
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pun - GuruFocus
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India - Sahm
Co-Diagnostics (Nasdaq: CODX) JV highlights TB, HPV PoC tests at VIROCON 2025 - Stock Titan
Finanzdaten der Co Diagnostics Inc-Aktie (CODX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):